… cells or cells within bronchioalveolar duct junctions, whereas … of oncogenic driver mutations
in KRAS, EGFR, HER2, MET … and adenocarcinomas, while Trp53 mutations are found in …

… % of lung adenocarcinomas and in around 5% to 7% of lung … needle aspiration,
bronchoalveolar lavage, pleural and … genes of interest (notably KRAS and HER2) are present in …

… of the primary tumor, such as mutations and gene amplification. … Her-2/neu receptor is an
erbB family tyrosine kinase receptor … adenocarcinoma other than bronchioloalveolar carcinoma. …

… In contrast, the NSCLC types are primarily adenocarcinomas, … (96,97) or lncRNAs (98)
present in bronchioalveolar lavage fluid (BALF) … In the FLAURA3 study, MET amplification, HER2 …

… 168 NSCLC-related genes on 949 advanced NSCLC patients … NSCLC (stage IIIB to IV)
patients with specific mutations in at … of patients, with all mutation clearance, only driver mutation …

… Adenocarcinoma is the most common type of NSCLC, … : either a kinase-activating mutation
in EGFR (EGFR-mutant) or … For example, HER2 mutant or amplified tumours with bypass ERK …

… de Valencia HER2: human epidermal growth factor receptor 2 … The sub-classification of
lung adenocarcinomas has … , in which terms such as bronchoalveolar carcinoma (BAC) or the …

… of mutations that cause a change in lung cancer described … of testing the HER2 mutation
in lung adenocarcinomas. The … of NSCLC are adenocarcinoma including Bronchioloalveolar …

… of typical human normal colon epithelium, adenoma and adenocarcinoma organoids … to
study the mutational status of single stem cells. The gradual accumulation of genetic mutations in …

… lung adenocarcinoma (LUAD) as the most common histologic … patients with lung cancer
require knowledge about mutated … ERBB2 (HER2) up-regulation is typically associated with low …